NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sense Neuro Diagnostics

Sense Neuro Diagnostics

Private
West Chester, PennsylvaniaHealthcare & Life Scienceshttps://senseneuro.com/

Last Round

Series B

Jan 19, 2026

Est. Valuation

$32M

Total Funding Raised

$5.98M

Company Overview

Sense Neuro Diagnostics is a healthtech company that develops non-invasive, AI-enabled neurodiagnostic medical devices for the rapid detection and continuous monitoring of stroke and traumatic brain injury.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials, Defense Tech, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

neurodiagnostic headsetstroke detectiontraumatic brain injuryTBImedical AIpoint-of-care diagnosticsbrain scanningnon-invasive monitoringRF-based sensingportable medical deviceclinical decision supportmedtechdefense medicinetriage technologywearable diagnostic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sense Neuro Diagnostics Comparables

Compare Sense Neuro Diagnostics with similar companies based on industry and business-model similarity.

Sense Neuro Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emvision Medical Devices
87%
Tiposi
85%
EMTensor
84%

Sense Neuro Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 19, 2026
Series BOct 3, 2025
VC RoundFeb 10, 2025
GrantNov 4, 2024
Early FundingMar 17, 2023
Grant
Aug 2, 2021

Key People

Founding team and executive leadership

Gary Kurdziel

Chief Executive Officer

Executive Team

Geoffrey Klass

Chief Executive Officer, CEO

Executive Team

George Shaw

Chief Technology Officer

Executive Team

Paul Gaitan

Chief Financial Officer

Executive Team

Sense Neuro Diagnostics Investors

Notable investors and investment history

Sense Neuro Diagnostics investors
InvestorRounds
QCA VenturesVC Round, Series A, Series B
U.S. Department of DefenseGrant
U.S. Department of WarGrant
U.S. Army Medical Research and Development CommandGrant
Dayton Development CoalitionVC Round, Series B
Medical Technology Enterprise ConsortiumGrant
Alloy Growth LabSeries B, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    Gary Kurdziel appointed as new Chief Executive Officer.

  • Mar 21, 2025

    Eric Bailey joins as the new Chief Commercial Officer.

Sense Neuro Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sense Neuro Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sense Neuro Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Chester, Pennsylvania
Employee Range12
Year Founded2013
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.